SNX » Topics » NOTE 7 - STOCKHOLDERS EQUITY:

This excerpt taken from the SNX 8-K filed Nov 3, 2005.

NOTE 8 - STOCKHOLDERS’ EQUITY:

 

Initial Public Offering

 

The Company completed its initial public offering (“IPO”) on December 1, 2003 and sold an aggregate of 3,578 shares of its common stock. In January 2004, the underwriters of the Company’s IPO exercised a portion of their over-allotment option and purchased an additional 161 shares of common stock from the Company. Net proceeds from the IPO and the exercise of the over-allotment option aggregated approximately $48,800.

 

Stock Options

 

During the three months ended February 29, 2004 and February 28, 2005, 18 and 70 stock options, respectively, were granted and at February 28, 2005 options to purchase 7,501 shares of common stock were outstanding.

 

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The Black-Scholes model, as well as other currently accepted option valuation models, was developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, and these assumptions differ significantly from the characteristics of Company stock option grants. The following weighted average assumptions were used to estimate the fair value of stock option grants in the three months ended February 29, 2004 and February 28, 2005:

 

     Three Months Ended

 
     February 28,
2005


    February 29,
2004


 

Expected life (years)

   5     5  

Risk-free interest rate

   3.5 %   3.1 %

Expected volatility

   33 %   65 %

Dividend yield

   0 %   0 %

 

-17-


SYNNEX CORPORATION

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

For the three months ended February 28, 2005 and February 29, 2004

(amounts in thousands, except for per share amounts)

(unaudited)

 

The weighted-average per share grant date fair value of options granted during the three months ended February 29, 2004 and February 28, 2005 was $9.29 and $7.36, respectively.

 

2003 Employee Stock Purchase Plan

 

The Company’s 2003 Employee Stock Purchase Plan (“ESPP”) permits eligible employees to purchase common stock through payroll deductions, which may not exceed 15% of an employee’s total compensation. The maximum number of shares a participant may purchase during a single accumulation period is one thousand two hundred fifty. The plan was approved by the Company’s stockholders and approved by its board of directors in 2003. A total of 500 shares of common stock have been reserved for issuance under the ESPP.

 

The ESPP has been implemented in a series of overlapping offering periods of 24 months’ duration, with new offering periods, other than the first offering period, beginning in October and April each year. Each offering period will consist of four accumulation periods of up to six months each. During each accumulation period, payroll deductions accumulate, without interest. On the last trading day of each accumulation period, accumulated payroll deductions are used to purchase common stock.

 

The purchase price equals 85% of the fair market value per share of common stock on either the first trading day of the offering period or on the last trading day of the accumulation period, whichever is less. If the fair market value of the Company’s stock at the start of an offering period is higher than the fair market value at the start of a subsequent offering period, then the first offering period will automatically terminate and participants will be automatically re-enrolled in the new offering period.

 

The payroll deductions in the first two accumulation periods resulted in the purchase of 200 shares of common stock. The fair value of each share is estimated on the date the employee enrolls in the ESPP using the Black-Scholes option-pricing model. The following weighted average assumptions were used to estimate the fair value of ESPP purchases in the accumulation periods ended March 31, 2004 and September 30, 2004:

 

Expected life (years)

   1.3  

Risk-free interest rate

   2.0 %

Expected volatility

   57.1 %

Dividend yield

   0 %

 

The weighted-average per share ESPP enrollment date fair value of common stock purchased during the accumulation periods was $5.23.

 

In March 2005, the Company’s board of directors approved the following amendments to the ESPP to be effective for the accumulation period beginning April 1, 2005:

 

    Reduction of participant purchase price discount of Company stock from 15% to 5%;

 

    Reduction of two year offering periods and six month accumulation periods to three month offering and accumulation periods;

 

    Maximum purchase limit of $10 of stock per calendar year per participant; and

 

    Director level employees and below are eligible to participate and associate vice president level employees and above are no longer eligible to participate.

 

-18-


SYNNEX CORPORATION

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

For the three months ended February 28, 2005 and February 29, 2004

(amounts in thousands, except for per share amounts)

(unaudited)

 

This excerpt taken from the SNX 10-Q filed Apr 11, 2005.

NOTE 7 - STOCKHOLDERS’ EQUITY:

 

Initial Public Offering

 

The Company completed its initial public offering (“IPO”) on December 1, 2003 and sold an aggregate of 3,578 shares of its common stock. In January 2004, the underwriters of the Company’s IPO exercised a portion of their over-allotment option and purchased an additional 161 shares of common stock from the Company. Net proceeds from the IPO and the exercise of the over-allotment option aggregated approximately $48,800.

 

Stock Options

 

During the three months ended February 29, 2004 and February 28, 2005, 18 and 70 stock options, respectively, were granted and at February 28, 2005 options to purchase 7,501 shares of common stock were outstanding.

 

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The Black-Scholes model, as well as other currently accepted option valuation models, was developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, and these assumptions differ significantly from the characteristics of Company stock option grants. The following weighted average assumptions were used to estimate the fair value of stock option grants in the three months ended February 29, 2004 and February 28, 2005:

 

     Three Months Ended

 
     February 28,
2005


    February 29,
2004


 

Expected life (years)

   5     5  

Risk-free interest rate

   3.5 %   3.1 %

Expected volatility

   33 %   65 %

Dividend yield

   0 %   0 %

 

The weighted-average per share grant date fair value of options granted during the three months ended February 29, 2004 and February 28, 2005 was $9.29 and $7.36, respectively.

 

2003 Employee Stock Purchase Plan

 

The Company’s 2003 Employee Stock Purchase Plan (“ESPP”) permits eligible employees to purchase common stock through payroll deductions, which may not exceed 15% of an employee’s total compensation. The maximum number of shares a participant may purchase during a single accumulation period is one thousand two hundred fifty. The plan was approved by the Company’s stockholders and approved by its board of directors in 2003. A total of 500 shares of common stock have been reserved for issuance under the ESPP.

 

The ESPP has been implemented in a series of overlapping offering periods of 24 months’ duration, with new offering periods, other than the first offering period, beginning in October and April each year. Each offering period will consist of four accumulation periods of up to six months each. During each accumulation period, payroll deductions accumulate, without interest. On the last trading day of each accumulation period, accumulated payroll deductions are used to purchase common stock.

 

17


Table of Contents

SYNNEX CORPORATION

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

For the three months ended February 28, 2005 and February 29, 2004

(amounts in thousands, except for per share amounts)

(unaudited)

 

The purchase price equals 85% of the fair market value per share of common stock on either the first trading day of the offering period or on the last trading day of the accumulation period, whichever is less. If the fair market value of the Company’s stock at the start of an offering period is higher than the fair market value at the start of a subsequent offering period, then the first offering period will automatically terminate and participants will be automatically re-enrolled in the new offering period.

 

The payroll deductions in the first two accumulation periods resulted in the purchase of 200 shares of common stock. The fair value of each share is estimated on the date the employee enrolls in the ESPP using the Black-Scholes option-pricing model. The following weighted average assumptions were used to estimate the fair value of ESPP purchases in the accumulation periods ended March 31, 2004 and September 30, 2004:

 

Expected life (years)

   1.3  

Risk-free interest rate

   2.0 %

Expected volatility

   57.1 %

Dividend yield

   0 %

 

The weighted-average per share ESPP enrollment date fair value of common stock purchased during the accumulation periods was $5.23.

 

In March 2005, the Company’s board of directors approved the following amendments to the ESPP to be effective for the accumulation period beginning April 1, 2005:

 

    Reduction of participant purchase price discount of Company stock from 15% to 5%;

 

    Reduction of two year offering periods and six month accumulation periods to three month offering and accumulation periods;

 

    Maximum purchase limit of $10 of stock per calendar year per participant; and

 

    Director level employees and below are eligible to participate and associate vice president level employees and above are no longer eligible to participate.

 

EXCERPTS ON THIS PAGE:

8-K
Nov 3, 2005
10-Q
Apr 11, 2005
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki